Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD

In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

BS Medicine Episode #598: Insomnia – hours of sleep is not the goal! – PART II

In episode 598, James and Mike continue to talk with David Gardner about the issue of insomnia. We discuss his latest, very cool, Your Answers When Needing Sleep (YAWNS NB)…
Listen 0.5 credits available

In the Clinic Episode #36: Heart Failure

In this episode of In the Clinic, Mike and Jess invite back Dr. Émélie Braschi. The team discusses Mr. Ramakanta, a 75-year-old man who is having trouble sleeping at night and difficulty breathing…
Listen 0.5 credits available

BS Medicine Episode #597: Insomnia – hours of sleep is not the goal!

In episode 597, James and Mike invite David Gardner to talk in depth about the issue of insomnia. We talk about triggers, precipitating factors, acute and chronic insomnia, and chronic…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Samantha Moe PharmD

Spearkers do not have any conflicts of interest to declare.